Corient Capital Partners, LLC Elanco Animal Health Inc Transaction History
Corient Capital Partners, LLC
- $1.34 Billion
- Q3 2022
A detailed history of Corient Capital Partners, LLC transactions in Elanco Animal Health Inc stock. As of the latest transaction made, Corient Capital Partners, LLC holds 19,092 shares of ELAN stock, worth $273,397. This represents 0.03% of its overall portfolio holdings.
Number of Shares
19,092
Previous 19,092
-0.0%
Holding current value
$273,397
Previous $375,000
-0.0%
% of portfolio
0.03%
Previous 0.03%
Shares
9 transactions
Others Institutions Holding ELAN
# of Institutions
447Shares Held
478MCall Options Held
3.1MPut Options Held
1.26M-
Dodge & Cox San Francisco, CA83.6MShares$1.2 Billion0.76% of portfolio
-
Primecap Management CO Pasadena, CA52.8MShares$756 Million0.56% of portfolio
-
Vanguard Group Inc Valley Forge, PA49.4MShares$708 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD28.1MShares$402 Million0.05% of portfolio
-
Black Rock Inc. New York, NY23.3MShares$334 Million0.01% of portfolio
About Elanco Animal Health Inc
- Ticker ELAN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 474,113,984
- Market Cap $6.79B
- Description
- Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...